Regiocontrolled S_NAr Reaction on 2,3-Dihalopyridines with NaSMe To Obtain Bromo(methylthio)pyridines as Key Precursors of 3-Halo-2-(hetero)arylthieno[2,3-b]pyridines and Thieno[3,2-b]pyridines

Abstract

The synthesis of 3-halo-2-(hetero)arylthieno[2,3-b]pyridines and 3-halo-2-(hetero)arylthieno[3,2-b]pyridines has been performed through a three-step methodology from 3-bromo-2-chloropyridine or 2-bromo-3-fluoropyridine, respectively. The key step of this methodology is the formation of the required bro­mo(methylthio)pyridines by a regiocontrolled nucleophilic aromatic substitution (S_NAr) with sodium methanethiolate (NaSMe). Then, the Sonogashira coupling with (hetero)arylalkynes followed by a halocyclization with bromine or iodine, afforded the expected 3-halo-2-(hetero)arylthienopyridines.

Key words

thienopyridines - nucleophilic aromatic substitution - methanethiolate - Sonogashira coupling - halocyclization

• References

• 1 Jenkins GL, Hartung WH. The Chemistry of Organic Medicinal Products . 3rd ed. Wiley; New York: 1949
• 2 Munchhof MJ, Beebe JS, Casavant JM, Cooper BA, Doty JL, Hidgon RC, Hillerman SM, Doderstrom CI, Knauth EA, Marx MA, Rossi AM. K, Sobolov SB, Sun J. Bioorg. Med. Chem. Lett. 2004; 14: 21
• 3 Saavedra O, Claridge S, Zhan L, Raeppel F, Granger M.-C, Raeppel S, Mannion M, Gaudette F, Zhou N, Isakovic L, Bernstein N, Déziel R, Nguyen H, Beaulieu N, Beaulieu C, Dupont I, Wang J, Macleod AR, Besterman JM, Vaisburg A. Bioorg. Med. Chem. Lett. 2009; 19: 6836
• 4a Claridge S, Raeppel F, Granger M.-C, Bernstein N, Saavedra O, Zhan L, Llewellyn D, Wahhab A, Deziel R, Rahil J, Beaulieu N, Nguyen H, Dupont I, Barsalou A, Beaulieu C, Chute I, Gravel S, Robert M.-F, Lefebvre S, Dubay M, Pascal R, Gillespie J, Jin Z, Wang J, Besterman JM, MacLeod AR, Vaisburg A. Bioorg. Med. Chem. Lett. 2008; 18: 2793
• 4b Raeppel S, Claridge S, Saavedra O, Gaudette F, Zhan L, Mannion M, Zhou N, Raeppel F, Granger M.-C, Isakovic L, Déziel R, Nguyen H, Beaulieu N, Beaulieu C, Dupont I, Robert M.-F, Lefebvre S, Dubay M, Rahil J, Wang J, Ste-Croix H, Macleod AR, Besterman J, Vaisburg A. Bioorg. Med. Chem. Lett. 2009; 19: 1323
• 5a Boschelli DH, Wu B, Sosa AC. B, Durutlic H, Ye F, Raifeld Y, Golas JM, Boschelli F. J. Med. Chem. 2004; 47: 6666
• 5b Boschelli DH, Sosa AC. B, Durutlic H, Chen JJ, Wang Y, Golas JM, Lucas J, Boschelli F. J. Med. Chem. 2005; 48: 3891
• 6a Berkaoui M, Outurquin F, Paulmier C. Tetrahedron 1998; 54: 9055
• 6b Ragan JA, Raggon JW, Hill PD, Jones BP, McDermott RE, Munchhof MJ, Marx MA, Casavant JM, Cooper BA, Doty JL, Lu Y. Org. Process Res. Dev. 2003; 7: 676
• 6c Nurkkala LJ, Steen RO, Dunne SJ. Synthesis 2006; 1295
• 6d Song Y-H, Jo BS. J. Heterocycl. Chem. 2009; 46: 1132
• 6e Shestopalov AM, Rodinovskaya LA, Shestopalov AA. J. Comb. Chem. 2010; 12: 9
• 7a Bremner DH, Dunn AD, Wilson KA. Synthesis 1992; 528
• 7b Bremner DH, Dunn AD, Wilson KA, Sturrock KR, Wishart C. Synthesis 1997; 949
• 7c Bremner DH, Dunn AD, Wilson KA, Sturrock KR, Wishart C. Synthesis 1998; 1095
• 7d Comoy C, Banaszak E, Fort Y. Tetrahedron 2006; 62: 6036
• 7e Nakashima T, Fujii R, Kawai T. Chem. Eur. J. 2011; 17: 10951
• 8 Calhelha RC, Queiroz M.-JR. P. Tetrahedron Lett. 2010; 51: 281
• 9a Queiroz M.-JR. P, Calhelha RC, Vale-Silva LA, Pinto E, Lima RT, Vasconcelos MH. Eur. J. Med. Chem. 2010; 45: 5628
• 9b Queiroz M.-JR. P, Calhelha RC, Vale-Silva LA, Pinto E, Almeida GM, Vasconcelos MH. Eur. J. Med. Chem. 2011; 46: 236
• 9c Abreu RM. V, Ferreira IC. F. R, Calhelha RC, Lima RT, Vasconcelos MH, Adega F, Chaves R, Queiroz M.-JR. P. Eur. J. Med. Chem. 2011; 46: 5800
• 9d Queiroz M.-JR. P, Calhelha RC, Vale-Silva LA, Pinto E, Nascimento MS.-J. Eur. J. Med. Chem. 2010; 45: 5732
• 10 Peixoto D, Begouin A, Queiroz M.-JR. P. Tetrahedron 2012; 68: 7082